People · Operator
Named in public records as an officer, director or promoter · active 2020–2023 · Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| eyeBrain Medical, Inc. | — | Biotechnology | Series C | $126.3M | $1.2B | 2022 |
| AccuVein Inc. | — | Other Health Care | Series B | $64.0M | $53.5M | 2020 |
Akhilesh Pathipati at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Akhilesh Pathipati on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Eric Bednarski | 2 | 7 |
| William Link | 1 | 11 |
| Stephen Reeders | 1 | 9 |
| Steve Kirby | 1 | 6 |
| J. Andy Corley | 1 | 5 |
| Ron Goldman | 1 | 3 |
| Tom Frinzi | 1 | 3 |
| Hugo Harrod | 1 | 3 |
| Steve T Kirby | 1 | 3 |
| CHRISTOPHER GABRIELI | 1 | 3 |
| Kevin McArdle | 1 | 3 |
| Christopher Hutchison | 1 | 2 |
| Rudy Mazzochi | 1 | 2 |
| James Lackie | 1 | 2 |
| William T. Link | 1 | 2 |
| Chuck Johnson | 1 | 2 |
| Pierre Bertrand | 1 | 2 |
| Brian Verrier | 1 | 2 |
| Daniel Perales | 1 | 1 |
| Dean Butler | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.